1. Smith HJ. Extrahepatic bile duct obstruction in primary carcinoma of the lung: incidence, diagnosis, and non-operative treatment. J Natl Med Assoc. 1980; 72:215–220. PMID:
6248647.
2. Moon SG, Han JK, Kim TK, Kim AY, Kim TJ, Choi BI. Biliary obstruction in metastatic disease: thin-section helical CT findings. Abdom Imaging. 2003; 28:45–52. PMID:
12483383.
Article
3. Lee YJ, Kim SH, Lee JY, Kim MA, Lee JM, Han JK, et al. Differential CT features of intraductal biliary metastasis and double primary intraductal polypoid cholangiocarcinoma in patients with a history of extrabiliary malignancy. AJR Am J Roentgenol. 2009; 193:1061–1069. PMID:
19770330.
Article
4. Park JS, Huh JW, Park YA, Cho YB, Yun SH, Kim HC, et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Medicine (Baltimore). 2015; 94:e658. PMID:
25881840.
Article
5. Popp JW Jr, Schapiro RH, Warshaw AL. Extrahepatic biliary obstruction caused by metastatic breast carcinoma. Ann Intern Med. 1979; 91:568–571. PMID:
484956.
Article
6. Maruyama K, Gunvén P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989; 210:596–602. PMID:
2818028.
7. Thomas JH, Pierce GE, Karlin C, Hermreck AS, MacArthur RI. Extrahepatic biliary obstruction secondary to metastatic cancer. Am J Surg. 1981; 142:770–773. PMID:
7316046.
Article
8. Papachristou D, Fortner JG. Biliary obstruction after gastrectomy for carcinoma of the stomach. Surg Gynecol Obstet. 1978; 147:401–404. PMID:
98852.
9. Riopel MA, Klimstra DS, Godellas CV, Blumgart LH, Westra WH. Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol. 1997; 21:1030–1036. PMID:
9298879.
10. Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdom Imaging. 2004; 29:540–547. PMID:
15383897.
Article
11. Colagrande S, Batignani G, Messerini L, Pinzani M. Intrabiliary metastasis from rectal cancer mimicking peripheral papillary-type cholangiocarcinoma. J Hepatol. 2004; 41:172–174. PMID:
15246230.
Article
12. Jain R, Fischer S, Serra S, Chetty R. The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol. 2010; 18:9–15. PMID:
19956064.
Article
13. Kaimaktchiev V, Terracciano L, Tornillo L, Spichtin H, Stoios D, Bundi M, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol. 2004; 17:1392–1399. PMID:
15205684.
Article
14. Iacopetta B, Russo A, Bazan V, Dardanoni G, Gebbia N, Soussi T, et al. TP53-CRC Collaborative Group. Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol. 2006; 17:842–847. PMID:
16524972.
Article